Mechanisms of transcriptional control of glucose metabolism in hepatocytes
https://doi.org/10.14341/DM2003436-40
Abstract
The hepatic tissue plays a key role in the regulation and maintenance of stable blood glucose levels. The liver is the main gluconeogenesis organ of the body and is under constant hormonal control to determine the metabolic activity of hepatocytes. Hormonal signals trigger multiple post-translational regulatory mechanisms that alter the activity of key enzymes of glucose metabolism. A crucial role in the long-term control of glucose production and metabolism is played by pre-translational regulation at the level of gene expression of metabolic enzymes. There is growing evidence that this regulation, which is realised via control of the activity of transcription factors, provides constant adjustment of the body to changing environmental conditions and that its disruption leads to the development of metabolic diseases associated with insulin resistance. Therefore, the study of transcription factors that regulate glucose metabolism in the liver and the search for mechanisms to control them is of great biomedical importance in the context of metabolic disease treatment research.
Supporting agencies: Russian Science Foundation (Grant # 14-35-00026 )
About the Authors
Konstantin Y. Kulebyakin
Lomonosov Moscow State University
Russian Federation
Competing Interests:
Russian Federation
Competing Interests:
No conflict of interest
Zhanna A. Akopyan
Lomonosov Moscow State University
Russian Federation
Competing Interests:
Russian Federation
MD, PhD, assistant professor
Competing Interests:
No conflict of interest
Tatiana N. Kochegura
Lomonosov Moscow State University
Russian Federation
MD, PhD
Competing Interests:
Russian Federation
MD, PhD
Competing Interests:
No conflict of interest
Dmitry N. Penkov
Lomonosov Moscow State University
Russian Federation
Competing Interests:
Russian Federation
PhD
Competing Interests:
No conflict of interest
References
1. Ivanov AI, Malkov AE, Waseem T, et al. Glycolysis and oxidative phosphorylation in neurons and astrocytes during network activity in hippocampal slices. J Cereb Blood Flow Metab. 2014;34(3):397-407. doi: 10.1038/jcbfm.2013.222
2. Climent F, Roset F, Repiso A, de la Ossa P. Red Cell Glycolytic Enzyme Disorders Caused by Mutations: An Update. Cardiovasc Hematol Disord Drug Targets. 2009;9(2):95-106. doi: 10.2174/187152909788488636.
3. Goveia J, Stapor P, Carmeliet P. Principles of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in disease. EMBO Mol Med. 2014;6(9):1105-1120. doi: 10.15252/emmm.201404156
4. Gromada J, Franklin I, Wollheim CB. Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains. Endocr Rev. 2007;28(1):84-116. doi: 10.1210/er.2006-0007
5. Jiang G, Zhang BB. Glucagon and regulation of glucose metabolism. Am J Physiol Endocrinol Metab. 2003;284(4):E671-678. doi: 10.1152/ajpendo.00492.2002
6. Rutter GA, Pullen TJ, Hodson DJ, et al. Pancreatic beta-cell identity, glucose sensing and the control of insulin secretion. Biochem J. 2015;466(2):203-218. doi: 10.1042/BJ20141384
7. Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 2001;414(6865):799-806. doi: 10.1038/414799a
8. She P, Shiota M, Shelton KD, et al. Phosphoenolpyruvate Carboxykinase Is Necessary for the Integration of Hepatic Energy Metabolism. Mol Cell Biol. 2000;20(17):6508-6517. doi: 10.1128/mcb.20.17.6508-6517.2000
9. Burgess SC, Hausler N, Merritt M, et al. Impaired tricarboxylic acid cycle activity in mouse livers lacking cytosolic phosphoenolpyruvate carboxykinase. J Biol Chem. 2004;279(47):48941-48949. doi: 10.1074/jbc.M407120200
10. Yang J, Reshef L, Cassuto H, et al. Aspects of the control of phosphoenolpyruvate carboxykinase gene transcription. J Biol Chem. 2009;284(40):27031-27035. doi: 10.1074/jbc.R109.040535
11. Marcolongo P, Fulceri R, Gamberucci A, et al. Multiple roles of glucose-6-phosphatases in pathophysiology: state of the art and future trends. Biochim Biophys Acta. 2013;1830(3):2608-2618. doi: 10.1016/j.bbagen.2012.12.013
12. Hutton JC, O’Brien RM. Glucose-6-phosphatase catalytic subunit gene family. J Biol Chem. 2009;284(43):29241-29245. doi: 10.1074/jbc.R109.025544
13. Durham SK. FKHR Binds the Insulin Response Element in the Insulin-Like Growth Factor Binding Protein-1 Promoter. Endocrinology. 1999;140(7):3140-3146. doi: 10.1210/en.140.7.3140
14. Calnan DR, Brunet A. The FoxO code. Oncogene. 2008;27(16):2276-2288. doi: 10.1038/onc.2008.21
15. Jacobs FMJ, van der Heide LP, Wijchers PJEC, et al. FoxO6, a Novel Member of the FoxO Class of Transcription Factors with Distinct Shuttling Dynamics. Journal of Biological Chemistry.2003;278(38):35959-35967. doi: 10.1074/jbc.M302804200
16. Barthel A, Schmoll D, Unterman TG. FoxO proteins in insulin action and metabolism. Trends Endocrinol Metab. 2005;16(4):183-189. doi: 10.1016/j.tem.2005.03.010
17. Sullivan IO, Zhang W, Wasserman DH, et al. FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization. Nat Commun. 2015;6:7079. doi: 10.1038/ncomms8079
18. Matsumoto M, Han S, Kitamura T, Accili D. Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. J Clin Invest. 2006;116(9):2464-2472. doi: 10.1172/JCI27047
19. Matsumoto M, Pocai A, Rossetti L, et al. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. Cell Metab. 2007;6(3):208-216. doi: 10.1016/j.cmet.2007.08.006
20. Hosaka T, Biggs WH, 3rd, Tieu D, et al. Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc Natl Acad Sci U S A. 2004;101(9):2975-2980. doi: 10.1073/pnas.0400093101
21. De Bock K, Georgiadou M, Schoors S, et al. Role of PFKFB3-driven glycolysis in vessel sprouting. Cell. 2013;154(3):651-663. doi: 10.1016/j.cell.2013.06.037
22. Rivera LB, Bergers G. Angiogenesis. Targeting vascular sprouts. Science. 2014;344(6191):1449-1450. doi: 10.1126/science.1257071
23. Nakae J, Biggs WH, 3rd, Kitamura T, et al. Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat Genet.2002;32(2):245-253. doi: 10.1038/ng890
24. Zhang W, Patil S, Chauhan B, et al. FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression. J Biol Chem. 2006;281(15):10105-10117. doi: 10.1074/jbc.M600272200
25. Zhao X, Gan L, Pan H, et al. Multiple elements regulate nuclear/cytoplasmic shuttling of FOXO1: characterization of phosphorylation- and 14-3-3-dependent and -independent mechanisms. Biochem J.2004;378(Pt 3):839-849. doi: 10.1042/BJ20031450
26. Lu M, Wan M, Leavens KF, et al. Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1. Nat Med. 2012;18(3):388-395. doi: 10.1038/nm.2686
27. Daitoku H, Hatta M, Matsuzaki H, et al. Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proc Natl Acad Sci U S A. 2004;101(27):10042-10047. doi: 10.1073/pnas.0400593101
28. Hori YS, Kuno A, Hosoda R, Horio Y. Regulation of FOXOs and p53 by SIRT1 modulators under oxidative stress. PLoS One. 2013;8(9):e73875. doi: 10.1371/journal.pone.0073875
29. Huang H, Tindall DJ. Dynamic FoxO transcription factors. J Cell Sci. 2007;120(Pt 15):2479-2487. doi: 10.1242/jcs.001222
30. Petersen CP, Reddien PW. Wnt signaling and the polarity of the primary body axis. Cell. 2009;139(6):1056-1068. doi: 10.1016/j.cell.2009.11.035
31. Abiola M, Favier M, Christodoulou-Vafeiadou E, et al. Activation of Wnt/beta-catenin signaling increases insulin sensitivity through a reciprocal regulation of Wnt10b and SREBP-1c in skeletal muscle cells. PLoS One. 2009;4(12):e8509. doi: 10.1371/journal.pone.0008509
32. Liu H, Fergusson MM, Wu JJ, et al. Wnt signaling regulates hepatic metabolism. Sci Signal. 2011;4(158):ra6. doi: 10.1126/scisignal.2001249
33. Mayr B, Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol. 2001;2(8):599-609. doi: 10.1038/35085068
34. Schmoll D, Wasner C, Hinds CJ, et al. Identification of a cAMP response element within the glucose- 6-phosphatase hydrolytic subunit gene promoter which is involved in the transcriptional regulation by cAMP and glucocorticoids in H4IIE hepatoma cells. Biochem J. 1999;338(2):457-463. doi: 10.1042/bj3380457
35. Hanson RW, Reshef L. Regulation of Phosphoenolpyruvate Carboxykinase (Gtp) Gene Expression. Annu Rev Biochem. 1997;66(1):581-611. doi: 10.1146/annurev.biochem.66.1.581
36. Herzig S, Long F, Jhala US, et al. Nature. 2001;413(6852):179-183. doi: 10.1038/35093131
37. Erion DM, Ignatova ID, Yonemitsu S, et al. Prevention of hepatic steatosis and hepatic insulin resistance by knockdown of cAMP response element-binding protein. Cell Metab. 2009;10(6):499-506. doi: 10.1016/j.cmet.2009.10.007
38. Koo SH, Flechner L, Qi L, et al. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature. 2005;437(7062):1109-1111. doi: 10.1038/nature03967
39. Dentin R, Liu Y, Koo SH, et al. Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2. Nature. 2007;449(7160):366-369. doi: 10.1038/nature06128
40. Liu Y, Dentin R, Chen D, et al. A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange. Nature. 2008;456(7219):269-273. doi: 10.1038/nature07349
41. Dentin R, Hedrick S, Xie J, et al. Hepatic glucose sensing via the CREB coactivator CRTC2. Science. 2008;319(5868):1402-1405. doi: 10.1126/science.1151363
42. Kim HS, Xiao C, Wang RH, et al. Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis. Cell Metab. 2010;12(3):224-236. doi: 10.1016/j.cmet.2010.06.009
43. Agius L. Glucokinase and molecular aspects of liver glycogen metabolism. Biochem J. 2008;414(1):1-18. doi: 10.1042/BJ20080595
44. Denton RM, Brownsey RW, Yeaman SJ. The Role of Phosphorylation in the Regulation of Fatty Acid Synthesis by Insulin and other Hormones [and Discussion]. Philosophical Transactions of the Royal Society B: Biological Sciences. 1983;302(1108):33-45. doi: 10.1098/rstb.1983.0036
45. Xu J, Christian B, Jump DB. Regulation of rat hepatic L-pyruvate kinase promoter composition and activity by glucose, n-3 polyunsaturated fatty acids, and peroxisome proliferator-activated receptor-alpha agonist. J Biol Chem. 2006;281(27):18351-18362. doi: 10.1074/jbc.M601277200
46. Girard J, Ferre P, Foufelle F. Mechanisms by which carbohydrates regulate expression of genes for glycolytic and lipogenic enzymes. Annu Rev Nutr. 1997;17:325-352. doi: 10.1146/annurev.nutr.17.1.325
47. Thompson KS, Towle HC. Localization of the carbohydrate response element of the rat L-type pyruvate kinase gene. Journal of Biological Chemistry. 1991;266(14):8679-8682.
48. Yamashita H, Takenoshita M, Sakurai M, et al. A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc. Natl. Acad Sci. U.S.A. 2001;98(16):9116-9121. doi: 10.1073/pnas.161284298
49. Iizuka K, Bruick RK, Liang G, et al. Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis. Proc Natl Acad Sci USA. 2004;101(19):7281-7286. doi: 10.1073/pnas.0401516101
50. Dentin R, Benhamed F, Pegorier JP, et al. Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation. J Clin Invest.2005;115(10):2843-2854. doi: 10.1172/JCI25256
51. Dentin R, Pegorier JP, Benhamed F, et al. Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression. J Biol Chem.2004;279(19):20314-20326. doi: 10.1074/jbc.M312475200
52. Havula E, Hietakangas V. Glucose sensing by ChREBP/MondoA-Mlx transcription factors. Semin Cell Dev Biol. 2012;23(6):640-647. doi: 10.1016/j.semcdb.2012.02.007
53. Sakiyama H, Wynn RM, Lee WR, et al. Regulation of nuclear import/export of carbohydrate response element-binding protein (ChREBP): interaction of an alpha-helix of ChREBP with the 14-3-3 proteins and regulation by phosphorylation. J Biol Chem. 2008;283(36):24899-24908. doi: 10.1074/jbc.M804308200
54. Kabashima T, Kawaguchi T, Wadzinski BE, Uyeda K. Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver. Proc Natl Acad Sci U S A. 2003;100(9):5107-5112. doi: 10.1073/pnas.0730817100
55. Ma L, Sham YY, Walters KJ, Towle HC. A critical role for the loop region of the basic helix-loop-helix/leucine zipper protein Mlx in DNA binding and glucose-regulated transcription. Nucleic Acids Res.2007;35(1):35-44. doi: 10.1093/nar/gkl987
56. Li MV, Chen W, Harmancey RN, et al. Glucose-6-phosphate mediates activation of the carbohydrate responsive binding protein (ChREBP). Biochem Biophys Res Commun. 2010;395(3):395-400. doi: 10.1016/j.bbrc.2010.04.028
57. Arden C, Tudhope SJ, Petrie JL, et al. Fructose 2,6-bisphosphate is essential for glucose-regulated gene transcription of glucose-6-phosphatase and other ChREBP target genes in hepatocytes. Biochem J.2012;443(1):111-123. doi: 10.1042/BJ20111280
58. Bricambert J, Miranda J, Benhamed F, et al. Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice. J Clin Invest.2010;120(12):4316-4331. doi: 10.1172/JCI41624
59. Guinez C, Filhoulaud G, Rayah-Benhamed F, et al. O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver. Diabetes. 2011;60(5):1399-1413. doi: 10.2337/db10-0452
60. Oosterveer MH, Mataki C, Yamamoto H, et al. LRH-1-dependent glucose sensing determines intermediary metabolism in liver. J Clin Invest. 2012;122(8):2817-2826. doi: 10.1172/JCI62368
Supplementary files
Review
For citations:
Kulebyakin K.Y., Akopyan Zh.A., Kochegura T.N., Penkov D.N. Mechanisms of transcriptional control of glucose metabolism in hepatocytes. Diabetes mellitus. 2016;19(3):190-198. (In Russ.) https://doi.org/10.14341/DM2003436-40
Views:
15978
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
